Intravenous Infusion of Mesenchymal Stem/Stromal Cells Decreased CCR7⁺ Antigen Presenting Cells in Mice with Corneal Allotransplantation

References

• English K, French A, Wood KJ. Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell 2010;7:431–442
   PubMed Web of Science ®Google Scholar
• Hoogduijn MJ, Popp FC, Grohnert A, Crop MJ, van Rhijn M, Rowshani AT, et al. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). Transplantation 2010;90:124–126
   PubMedGoogle Scholar
• Uccelli A, Prockop DJ. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol 2010;22:768–774
   PubMedGoogle Scholar
• Ren G, Su J, Zhang L, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008;2:141–150
   PubMed Web of Science ®Google Scholar
• Lee RH, Oh JY, Choi H, Bazhanov N. Therapeutic factors secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem 2012;112:3073–3078
   Google Scholar
• Oh JY, Lee RH, Yu JM, Ko JH, Lee HJ, Ko AY, et al. Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol Ther 2012;20:2143–2152
   PubMed Web of Science ®Google Scholar
• Hume DA. Macrophages as APC and the dendritic cell myth. J Immunol 2008;181:5829–5835
   PubMed Web of Science ®Google Scholar
• Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 2004;202:96–105
   PubMed Web of Science ®Google Scholar
• Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol 2012;13:722–728
   PubMed Web of Science ®Google Scholar
• Boisgérault F, Liu Y, Anosova N, Ehrlich E, Dana MR, Benichou G. Role of CD4+ and CD8+ T cells in allorecognition: lessons from corneal transplantation. J Immunol 2001;167:1891–1899
   PubMed Web of Science ®Google Scholar
• Niederkorn JY. Immune mechanisms of corneal allograft rejection. Curr Eye Res 2007;32:1005–1016
   PubMed Web of Science ®Google Scholar
• Choy JC. Granzymes and perforin in solid organ transplant rejection. Cell Death Differ 2010;17:567–576
   PubMed Web of Science ®Google Scholar
• Schlereth S, Lee HS, Khandelwal P, Saban DR. Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis. Am J Pathol 2012;180:2351–2360
   PubMedGoogle Scholar
• Jin Y, Shen L, Chong EM, Hamrah P, Zhang Q, Chen L, et al. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis 2007;13:626–634
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245–252
   PubMed Web of Science ®Google Scholar
• Förster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008;8:362–371
   PubMed Web of Science ®Google Scholar
• MartIn-Fontecha A, Sebastiani S, Höpken UE, Uguccioni M, Lipp M, Lanzavecchia A, et al. Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J Exp Med 2003;198:615–621
   PubMed Web of Science ®Google Scholar
• Beckmann JH, Yan S, Lührs H, Heid B, Skubich S, Förster R, et al. Prolongation of allograft survival in CCR7-deficient mice. Transplantation 2004;12:1809–1814
   Google Scholar
• Ziegler E, Gueler F, Rong S, Mengel M, Witzke O, Kribben A, et al. CL19-IgG prevents allograft rejection by impairment of immune cell trafficking. J Am Soc Nephrol 2006;17:2521–2532
   PubMedGoogle Scholar
• Wang L, Han R, Lee I, Hancock AS, Xiong G, Gunn MD, et al. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway. J Immunol 2005;175:6311–6318
   PubMedGoogle Scholar
• Schlereth S, Lee HS, Khandelwal P, Saban DR. Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis. Am J Pathol. 2012;180:2351–2360
   PubMedGoogle Scholar
• English K, Barry FP, Mahon BP. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 2008;115:50–58
   PubMed Web of Science ®Google Scholar
• Chiesa S, Morbelli S, Morando S, Massollo M, Marini C, Bertoni A, et al. Menchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc Natl Acad Sci USA 2011;108:17384–17389
   PubMed Web of Science ®Google Scholar
• Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009;5:54–63
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006;36:2566–2573
   PubMed Web of Science ®Google Scholar
• Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;107:1484–1490
   PubMed Web of Science ®Google Scholar
• Prigione I, Benvenuto F, Bocca P, Battistini L, Uccelli A, Pistoia V. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells 2009;27:693–702
   PubMed Web of Science ®Google Scholar
• Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006;108:2114–2220
   PubMed Web of Science ®Google Scholar
• Dana R. Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2007;105:330–343
   PubMedGoogle Scholar